Overview News & Events Press Releases Events & Presentations Analyst Coverage Stock Information Stock Quote & Chart Financials & Filings SEC Filings Corporate Governance Documents & Charters Management Board of Directors Committee Composition Resources Investor FAQs Email Alerts Contact IR Overview News & Events Press Releases Events & Presentations Analyst Coverage Stock Information Stock Quote & Chart Financials & Filings SEC Filings Corporate Governance Documents & Charters Management Board of Directors Committee Composition Resources Investor FAQs Email Alerts Contact IR Press Releases Year None2023202220212020 Mar 06, 2023 Invivyd Optimizes Development Efficiency with Election of VYD222 for Near-Term Clinical Advancement to Address Urgent Unmet Need for COVID-19 Monoclonal Antibodies Feb 28, 2023 Invivyd to Participate at Cowen’s 43rd Annual Healthcare Conference Feb 03, 2023 Invivyd Announces Changes to Executive Team First page « first Previous page ‹ previous Page 1 Current page 2 Displaying 11 - 13 of 13
Year None2023202220212020 Mar 06, 2023 Invivyd Optimizes Development Efficiency with Election of VYD222 for Near-Term Clinical Advancement to Address Urgent Unmet Need for COVID-19 Monoclonal Antibodies Feb 28, 2023 Invivyd to Participate at Cowen’s 43rd Annual Healthcare Conference Feb 03, 2023 Invivyd Announces Changes to Executive Team First page « first Previous page ‹ previous Page 1 Current page 2 Displaying 11 - 13 of 13
Mar 06, 2023 Invivyd Optimizes Development Efficiency with Election of VYD222 for Near-Term Clinical Advancement to Address Urgent Unmet Need for COVID-19 Monoclonal Antibodies
